Nanomaterials a risk to health at work? First International Symposium on Occupational Health Implications of Nanomaterials 12-14 October 2004, Buxton, Derbyshire, UK. Buxton, Derbyshire, UK: Health and Safety Laboratory, 2004 Oct; :113
The National Occupational Research Agenda (NORA) was initiated in April 1996 by the National Institute for Occupational Safety and Health (NIOSH) and its business, labor, academic, and government partners. NORA is directing and focusing occupational safety and health research in 21 areas to produce improvements in worker safety and health. Information about NORA is available at <a href="https://www.cdc.gov/niosh/"target="_blank">https://www.cdc.gov/niosh/</a>. The NORA Mixed Exposures Team is considering mixed exposure scenarios relevant to nanotechnology safety and health, including health concerns for nanoparticles and nanomaterials in a range of particle sizes; mixed dermal and inhalation exposure pathways; multiple simultaneous exposures to individual agents; exposures to different agents at different times in workers' lives; generic classes of nanoparticles or nanomaterials with multiple components; and the combined effect of other stressors such as heat on nanoparticle exposures and behavior. Insights into health and safety issues for nanotechnology may come from lessons learned in studies of complex mixtures such as asphalt fumes, welding fumes, fossil fuels, and combustion products. The NORA program is also interested in the possibility that advances in nanotechnology may create tools to better enable research on mixed exposures; e.g. development of nanosensors that can be used to study health effects from exposure to mixtures (not necessarily involving nanoparticles). The NORA Mixed Exposures Team invites collaboration to improve the anticipation, measuring, modeling, and mitigation of potential health effects from nanotechnology activities.
Nanomaterials a risk to health at work? First International Symposium on Occupational Health Implications of Nanomaterials 12-14 October 2004, Buxton, Derbyshire, UK
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.
CDC.gov Privacy Settings
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.
Thank you for taking the time to confirm your preferences. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page.